Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Deferred Taxes (2019 - 2026)

Viatris (VTRS) posted Deferred Taxes of -$124.5 million for Q2 2026, down 78.62% on a QoQ basis from -$69.7 million in Q1 2026, and down 162.11% year-over-year from $200.5 million in Q2 2025.

Analysis

Viatris (VTRS) Deferred Taxes (2019 - 2026) Analysis & Trends

Viatris has reported Deferred Taxes for 8 years, with the latest figure at -$124.5 million in Q2 2026.

  • On a quarterly basis, Deferred Taxes fell 162.11% year-over-year to -$124.5 million in Q2 2026; TTM through Jun 2026 was -$579.6 million, a 11.16% increase from a year earlier, with the FY2025 full-year figure at -$476.5 million, up 37.92% from the prior year.
  • Deferred Taxes was -$124.5 million for Q2 2026 at Viatris, down from -$69.7 million in the prior quarter.
  • The five-year high for Deferred Taxes was $153.6 million in Q4 2022, with the low at -$312.4 million in Q3 2024.
  • Average Deferred Taxes over 5 years is -$102.8 million, with a median of -$77.4 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2023: Deferred Taxes surged 390.36% in 2022, then plunged 288.13% in 2023.
  • Over 5 years, Deferred Taxes stood at $153.6 million in 2022, then tumbled by 234.9% to -$207.2 million in 2023, then retreated by 20.13% to -$248.9 million in 2024, then rose by 0.28% to -$248.2 million in 2025, then jumped by 49.84% to -$124.5 million in 2026.
  • The last three Deferred Taxes figures came in at -$124.5 million (Q2 2026), -$69.7 million (Q1 2026), and -$248.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 25.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -124.50 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 12.44 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 17.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 59,000.00
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -4.94 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -124.50 Mn
Mar 31, 2026 -69.70 Mn
Dec 31, 2025 -248.20 Mn
Sep 30, 2025 -137.20 Mn
Jun 30, 2025 -47.50 Mn
Mar 31, 2025 -43.60 Mn
Dec 31, 2024 -248.90 Mn
Sep 30, 2024 -312.40 Mn
Jun 30, 2024 -154.40 Mn
Mar 31, 2024 -51.90 Mn
Dec 31, 2023 -207.20 Mn
Sep 30, 2023 -85.00 Mn
Jun 30, 2023 -68.20 Mn
Mar 31, 2023 -26.70 Mn
Dec 31, 2022 153.60 Mn
Sep 30, 2022 -21.90 Mn
Jun 30, 2022 -104.80 Mn
Mar 31, 2022 -52.80 Mn
Dec 31, 2021 -52.90 Mn
Sep 30, 2021 147.00 Mn